PCI Biotech Holding, акция обыкновенная (NO0010405640, PCIB, 0JGL, 4QG)

PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform. The company is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of cancer), fimaVACC (T-cell induction technology for therapeutic vaccination), and fimaNAc (nucleic acid therapeutics delivery).

• Активы
• Капитал
• Общий долг / Капитал
• Выручка
• Чистая прибыль
• EBITDA
• Рентабельность по EBITDA (%)
• Чистый долг / EBITDA